This is the login page for PHARMA JAPAN WEB subscribers. PHARMA JAPAN WEB offers excerpts of some articles for free, but paid subscription is required to read full articles.
Pharma, Govt Hold 1st Kanmin Taiwa Working Group Talks; Industry Calls for Trial-Friendly Environment, Discussions on PricingRepresentatives of major pharma trade associations and the government met on September 21 for their first working group meeting for “public-private dialogue (kanmin taiwa)” to exchange views over issues that ...
- Takeda, France’s Affilogic Join Hands on CNS Drugs (Sep.23)
- Takeda Ties Up with India’s Zydus Cadila for Chikungunya Vaccine (Sep.23)
- Univ. of Tokyo to Launch Probe into 22 Scientific Papers after Data Manipulation Claims (Sep.23)
- Maruho Gets Japan Rights to Dermira’s Hyperhidrosis Treatment (Sep.23)
- Sumitomo Dainippon’s ADHD Drug Meets Primary Endpoint in US PII/III Study in Children (Sep.23)
|AMED Official Outlines Pre-Orphan Designation Support Scheme (Sep.20)||Industry Chiefs, Chuikyo Panelists Trade Barbs over Market Expansion on Add’l Indications (Sep.15)||3 Pharma Groups Firmly Oppose Out-of-Cycle Re-Pricing at Chuikyo (Sep.15)|
|Novartis Eager to See More 1st Approvals in Japan despite Pricing Headache (Sep.14)||Blue Book “Will Be Used as Reference When Selecting Generics”: Panel Chair (Sep.14)||G7 Health Ministers Adopt Kobe Communique (Sep.13)|
- Pharma, Govt Hold 1st Kanmin Taiwa Working Group Talks; Industry Calls for Trial-Friendly Environment, Discussions on Pricing(Sep.23)
- Panel Backs Approval of Add’l Indication for J-TEC’s Cell Sheet JACE(Sep.21)
- Combo Use of 2 Different Hep B Vaccines Produced Necessary Antibody Titer, No Serious ADRs: Report(Sep.21)
- Japan Wholesaler Chief Suzuki to Become IFPW Vice Chairman(Sep.16)
- Japan Needs Listing Rule Conditional on Possible Ad-Hoc Re-Pricing: Kono(Sep.07)
- Kenporen’s Kono Pushes for “Huge Seller” Re-Pricing for Opdivo before 2018(Sep.07)